The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
作者信息
Wechsler Lawrence R
机构信息
From the Department of Neurology, University of Pittsburgh Medical School, PA.
出版信息
Stroke. 2014 Mar;45(3):914-5. doi: 10.1161/STROKEAHA.113.002701. Epub 2014 Feb 13.
PMID:24526061
Abstract
摘要
相似文献
1
The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.静脉注射组织型纤溶酶原激活剂进行静脉溶栓的4.5小时时间窗尚未完全确立。
Stroke. 2014 Mar;45(3):914-5. doi: 10.1161/STROKEAHA.113.002701. Epub 2014 Feb 13.
2
4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.重组组织型纤溶酶原激活剂静脉溶栓的4.5小时时间窗已被牢固确立。
Stroke. 2014 Mar;45(3):912-3. doi: 10.1161/STROKEAHA.113.002700. Epub 2014 Feb 13.
3
Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?3至4.5小时时间窗内的溶栓治疗：对ECASS持怀疑态度者想要什么？
Stroke. 2014 Mar;45(3):916-7. doi: 10.1161/STROKEAHA.113.004265. Epub 2014 Feb 13.
4
Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.在选定患者急性缺血性卒中发病后三小时内进行动脉内溶栓治疗。
Stroke. 2009 Jul;40(7):2611-2. doi: 10.1161/STROKEAHA.109.549568. Epub 2009 May 14.
5
Thrombolysis, community hospitals, and primary stroke center.溶栓治疗、社区医院与初级卒中中心
Acta Neurol Taiwan. 2009 Mar;18(1):1-2.
6
IV and IA thrombolytic stroke strategies are complementary.静脉内和动脉内溶栓治疗中风的策略是相辅相成的。
Stroke. 2009 Jul;40(7):2615. doi: 10.1161/STROKEAHA.109.549709. Epub 2009 May 14.
7
Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
Stroke. 2009 Jul;40(7):2613-4. doi: 10.1161/STROKEAHA.109.549766. Epub 2009 May 14.
8
Intravenous or intra-arterial thrombolysis?: it's time to find the right approach for the right patient.静脉溶栓还是动脉内溶栓？是时候为合适的患者找到正确的治疗方法了。
Stroke. 2007 Jul;38(7):2038-40. doi: 10.1161/STROKEAHA.107.487124. Epub 2007 May 31.
9
Current acute stroke trials and their potential impact on the therapeutic time window.当前急性脑卒中试验及其对治疗时间窗的潜在影响。
Expert Rev Neurother. 2012 Feb;12(2):169-77. doi: 10.1586/ern.11.198.
10
Randomised trials of endovascular treatment of stroke are needed.需要进行中风血管内治疗的随机试验。
Lancet Neurol. 2010 Jan;9(1):30; author reply 31-2. doi: 10.1016/S1474-4422(09)70349-7.
引用本文的文献
1
Perspective: Patient Apprehensions Prolonged Stroke Presentation During the COVID-19 Pandemic.观点：在新冠疫情期间患者的担忧延长了卒中就诊时间
World Neurosurg. 2022 Aug;164:241-242. doi: 10.1016/j.wneu.2022.05.083. Epub 2022 May 23.
2
A Clinical Observation of Intravenous Thrombolysis in Acute Ischemic Stroke with Minor Trauma.急性缺血性卒中轻微创伤患者静脉溶栓的临床观察
Neuropsychiatr Dis Treat. 2021 Jun 17;17:1983-1987. doi: 10.2147/NDT.S290443. eCollection 2021.
3
Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset.症状发作3小时内与3至4.5小时内急性缺血性卒中的静脉溶栓治疗
Neurohospitalist. 2015 Jul;5(3):101-9. doi: 10.1177/1941874415583116.
Zotero 插件